Sigrun Unger

1.1k total citations
37 papers, 891 citations indexed

About

Sigrun Unger is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Sigrun Unger has authored 37 papers receiving a total of 891 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cardiology and Cardiovascular Medicine, 15 papers in Pulmonary and Respiratory Medicine and 11 papers in Physiology. Recurrent topics in Sigrun Unger's work include Pulmonary Hypertension Research and Treatments (15 papers), Heart Failure Treatment and Management (8 papers) and Nitric Oxide and Endothelin Effects (7 papers). Sigrun Unger is often cited by papers focused on Pulmonary Hypertension Research and Treatments (15 papers), Heart Failure Treatment and Management (8 papers) and Nitric Oxide and Endothelin Effects (7 papers). Sigrun Unger collaborates with scholars based in Germany, United States and Austria. Sigrun Unger's co-authors include Reiner Frey, Wolfgang Mück, Georg Wensing, Corina Becker, Gerrit Weimann, Dirk Thomas, Wolfgang Mueck, Ashraf Yassen, Stephan Schwers and Iréne Lang and has published in prestigious journals such as Circulation, CHEST Journal and European Respiratory Journal.

In The Last Decade

Sigrun Unger

36 papers receiving 873 citations

Peers

Sigrun Unger
Robert E. Bowden United States
Ferhana Y. Ali United Kingdom
M.P. Gordge United Kingdom
Reiner Frey Germany
Bianca M. Simonetti Italy
Patricia Price United States
Stephen A. Katz United States
Akira Suehiro Japan
C Lechi Italy
Robert E. Bowden United States
Sigrun Unger
Citations per year, relative to Sigrun Unger Sigrun Unger (= 1×) peers Robert E. Bowden

Countries citing papers authored by Sigrun Unger

Since Specialization
Citations

This map shows the geographic impact of Sigrun Unger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sigrun Unger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sigrun Unger more than expected).

Fields of papers citing papers by Sigrun Unger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sigrun Unger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sigrun Unger. The network helps show where Sigrun Unger may publish in the future.

Co-authorship network of co-authors of Sigrun Unger

This figure shows the co-authorship network connecting the top 25 collaborators of Sigrun Unger. A scholar is included among the top collaborators of Sigrun Unger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sigrun Unger. Sigrun Unger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Dirk, et al.. (2021). First evaluation of the safety, pharmacokinetics, and pharmacodynamics of BAY 2433334, a small molecule targeting coagulation factor XIa. Journal of Thrombosis and Haemostasis. 19(10). 2407–2416. 59 indexed citations
2.
Thomas, Dirk, Kirstin Thelen, Stefanie Kraff, et al.. (2019). BAY 1213790, a fully human IgG1 antibody targeting coagulation factor XIa: First evaluation of safety, pharmacodynamics, and pharmacokinetics. Research and Practice in Thrombosis and Haemostasis. 3(2). 242–253. 58 indexed citations
3.
DeJesus, Edwin, Soundos Saleh, Corina Becker, et al.. (2018). Pharmacokinetic (PK) interaction of fixed-dose combination (FDC) antiretrovirals (ARV) with riociguat (rio). PA3036–PA3036. 1 indexed citations
4.
Frey, Reiner, et al.. (2017). Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat. Clinical Pharmacokinetics. 57(6). 647–661. 53 indexed citations
5.
Frey, Reiner, Michaël Reber, Jörn Krätzschmar, et al.. (2016). Riociguat (BAY 63‐2521) and Aspirin: A Randomized, Pharmacodynamic, and Pharmacokinetic Interaction Study. Pulmonary Circulation. 6(S1). S35–42. 11 indexed citations
6.
Becker, Corina, Reiner Frey, Christiane Hesse, et al.. (2016). Absorption of Riociguat (BAY 63‐2521): Bioavailability, Food Effects, and Dose Proportionality. Pulmonary Circulation. 6(S1). S27–34. 12 indexed citations
7.
Becker, Corina, Reiner Frey, Sigrun Unger, et al.. (2016). Pharmacokinetic Interaction of Riociguat with Ketoconazole, Clarithromycin, and Midazolam. Pulmonary Circulation. 6(S1). 24 indexed citations
8.
9.
Frey, Reiner, Corina Becker, Sigrun Unger, et al.. (2016). Assessment of the Effects of Renal Impairment and Smoking on the Pharmacokinetics of a Single Oral Dose of the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63‐2521). Pulmonary Circulation. 6(S1). S15–26. 22 indexed citations
10.
Becker, Corina, et al.. (2016). Effects of Omeprazole and Aluminum Hydroxide/Magnesium Hydroxide on Riociguat Absorption. Pulmonary Circulation. 6(S1). S43–8. 8 indexed citations
11.
Saleh, Soundos, Reiner Frey, Corina Becker, et al.. (2016). Bioavailability, Pharmacokinetics, and Safety of Riociguat Given as an Oral Suspension or Crushed Tablet with and without Food. Pulmonary Circulation. 6(S1). S66–74. 9 indexed citations
12.
Frey, Reiner, Sigrun Unger, Corina Becker, et al.. (2016). Pharmacokinetic Interaction Study between Riociguat and the Combined Oral Contraceptives Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women. Pulmonary Circulation. 6(S1). S97–S102. 12 indexed citations
13.
Ghofrani, Hossein Ardeschir, Gerd Staehler, Ekkehard Grünig, et al.. (2015). Acute Effects of Riociguat in Borderline or Manifest Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease. Pulmonary Circulation. 5(2). 296–304. 30 indexed citations
14.
15.
Bonderman, Diana, Ingrid Pretsch, Regina Steringer‐Mascherbauer, et al.. (2014). Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1). CHEST Journal. 146(5). 1274–1285. 198 indexed citations
16.
Becker, Corina, Reiner Frey, Sigrun Unger, et al.. (2013). Pharmacokinetic (PK) interaction of ketoconazole (KC), clarithromycin (CM) and midazolam (MZ) with riociguat. European Respiratory Journal. 42(Suppl 57). P4068–P4068. 1 indexed citations
17.
Frey, Reiner, Wolfgang Mück, Mark Jean Gnoth, et al.. (2011). Pharmacokinetics of the Soluble Guanylate Cyclase Activator Cinaciguat in Individuals With Hepatic Impairment. The Journal of Clinical Pharmacology. 52(11). 1714–1724. 4 indexed citations
18.
Ghofrani, Hossein Ardeschir, Gerd Staehler, Ekkehard Gruenig, et al.. (2011). The Effect Of The Soluble Guanylate Cyclase Stimulator Riociguat On Hemodynamics In Patients With Pulmonary Hypertension Due To Chronic Obstructive Pulmonary Disease. A6127–A6127. 7 indexed citations
19.
Frey, Reiner, et al.. (2008). Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Activator Cinaciguat (BAY 58‐2667) in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 48(12). 1400–1410. 56 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert E. Bowden Breakdown of academic impact, for papers by Ferhana Y. Ali Breakdown of academic impact, for papers by M.P. Gordge Breakdown of academic impact, for papers by Reiner Frey Breakdown of academic impact, for papers by Bianca M. Simonetti Breakdown of academic impact, for papers by Patricia Price Breakdown of academic impact, for papers by Stephen A. Katz Breakdown of academic impact, for papers by Akira Suehiro Breakdown of academic impact, for papers by C Lechi
Rankless by CCL
2026